Evidence map›Paper›PMID 29966877›Full record

ArticleEnvironmental research2018

Cross sectional association of arsenic and seroprevalence of hepatitis B infection in the United States (NHANES 2003-2014).

Andres Cardenas, Ellen Smit, Barrett M Welch, Jeff Bethel, Molly L Kile

Open access · greenAbstract read
In one paragraph

Article in Environmental research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Toxic metal exposure as a possible risk factor for COVID-19 and other respiratory infectious diseases.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2020
    Pooled it
  2. Review
  3. Mechanisms of Metal-Induced Hepatic Inflammation.Current environmental health reports · 2024
    Review
  4. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The interplay between environmental exposures and COVID-19 risks in the health of children.Environmental health : a global access science source · 2021
    Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Andres CardenasDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, United States.
Ellen SmitOregon State University, College of Public Health and Human Sciences, 101 Milam Hall, Corvallis, OR 97331, United States.
Barrett M WelchOregon State University, College of Public Health and Human Sciences, 101 Milam Hall, Corvallis, OR 97331, United States.
Jeff BethelOregon State University, College of Public Health and Human Sciences, 101 Milam Hall, Corvallis, OR 97331, United States.
Molly L KileOregon State University, College of Public Health and Human Sciences, 101 Milam Hall, Corvallis, OR 97331, United States. Electronic address: molly.kile@oregonstate.edu.
Oregon State University · USHarvard University · US

Funding

Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
Developmental Exposure to Arsenic and Immune Function in ChildrenR01ES023441 · NIEHS · OREGON STATE UNIVERSITY · PI KILE, MOLLY L · 2014 to 2018
$1.5M
NIEHS NIH HHS P30 ES000210NIEHS NIH HHS R01 ES023441
6 · The paper itself

Abstract

backgroundArsenic alters immunological parameters including antibody formation and antigen-driven T-cell proliferation.

objectiveWe evaluated the cross-sectional relationship between urinary arsenic and the seroprevalence of hepatitis B (HBV) infection in the United States using data from six pooled cycles of the National Health and Nutrition Examination Survey (2003-2014, N = 12,447).

methodsUsing serological data, participants were classified as susceptible, immune due to vaccination, or immune due to past natural infection. We used multinomial logistic regression to evaluate the association between urinary DMA and HBV classification. A sensitivity analysis using total urinary arsenic (TUA) was also conducted. Both DMA and TUA were adjusted for arsenobetaine using a residual regression method

resultsA 1-unit increase in the natural logarithm (ln) of DMA was associated with 40% greater adjusted odds of having immunity due to natural infection compared to being susceptible (Odds Ratio [aOR]: 1.40, 95% Confidence Intervals [CI] 1.15, 1.69), 65% greater odds of having immunity due to a natural infection (aOR: 1.65, 95% CI: 1.34, 2.04) and 18% greater odds of being susceptible (aOR: 1.18, 95% CI: 1.05, 1.33) compared to being immune due to vaccination after adjusting for creatinine, age, sex, race, income, country of birth, BMI, survey cycle, serum cotinine, recent seafood intake, and self-reported HBV immunization status.

conclusionIn the U.S. general public, higher urinary arsenic levels were associated with a greater odds of having a serological classification consistent with a past natural hepatitis B infection after adjusting for other risk factors. Additionally, higher urinary arsenic levels were linked to a greater odds of not receiving hepatitis B vaccinations. Given the cross-sectional nature of this analysis, more research is needed to test the hypothesis that environmentally relevant exposure to arsenic modulates host susceptibility to hepatitis B virus.

Indexed as

ArsenicCross-Sectional StudiesHepatitis BHumansNutrition SurveysSeroepidemiologic StudiesUnited StatesArsenicAntibody responsesAnti-HBcAnti-HBsCore antibodyEpidemiologyHBVHeavy metalsHepatitis surface antigenImmunotoxicityInfectious diseaseSurface antibodyViral hepatitis

Identifiers

PMID29966877
PMCPMC9612408
OpenAlexW2811305577

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.